Skip to Main content Skip to Navigation
New interface
Journal articles

Ex vivo T cell-based HIV suppression assay to evaluate HIV-specific CD8+ T-cell responses

Abstract : To advance T cell-based HIV vaccine development, it is necessary to evaluate the immune correlates of a protective CD8(+) T-cell response. We have developed an assay that assesses the capacity ex vivo of HIV-specific CD8(+) T cells to suppress HIV-1 infection of autologous CD4(+) T cells. This assay directly reflects the ultimate effector function of CD8(+) T cells, the elimination of infected cells, and accurately differentiates the effective CD8(+) T-cell response in spontaneous HIV controllers from ineffective responses in other patients. In this article, we describe all the steps from cell purification to assessment of viral replication by HIV-p24 ELISA and analysis, along with conditions for cell culturing, and how to choose the viral infectious dose that gives the most reliable results. We also depict the conditions of a rapid assay on the basis of flow cytometry analysis of intracellular HIV-Gag products. These procedures take 14-17 d when the p24 ELISA assay is used, or 6 d with the intracellular Gag assay.
Document type :
Journal articles
Complete list of metadata

Cited literature [26 references]  Display  Hide  Download
Contributor : Marie-Genevieve Guibert Connect in order to contact the contributor
Submitted on : Tuesday, May 16, 2017 - 1:21:22 PM
Last modification on : Thursday, April 7, 2022 - 10:10:23 AM
Long-term archiving on: : Friday, August 18, 2017 - 12:24:59 AM


Files produced by the author(s)


Distributed under a Creative Commons Attribution - NonCommercial - ShareAlike 4.0 International License




Asier Saez-Cirion, So Youn Shin, Pierre Versmisse, Françoise Barré-Sinoussi, Gianfranco Pancino. Ex vivo T cell-based HIV suppression assay to evaluate HIV-specific CD8+ T-cell responses. Nature Protocols, 2010, 5 (6), pp.1033--1041. ⟨10.1038/nprot.2010.73⟩. ⟨pasteur-01420584⟩



Record views


Files downloads